| mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.9 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
1 |
| mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
1 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
| mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |